跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REMINYL galantamine 8mg (as hydrobromide) modified release capsule - TGA Drug Approval Details
Approvals
/
TGA
/
REMINYL galantamine 8mg (as hydrobromide) modified release capsule
Approved
STANDARD
REMINYL galantamine 8mg (as hydrobromide) modified release capsule
Clinect Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
b28ba4fb0a157840
Company
Clinect Pty Ltd
Type
Standard
Approval Details
Approval Id
b28ba4fb0a157840
Product Name
REMINYL galantamine 8mg (as hydrobromide) modified release capsule
Artg Id
97883
Artg Name
REMINYL galantamine 8mg (as hydrobromide) modified release capsule blister pack
Sponsor
Clinect Pty Ltd
Company Detail Path
/organization/clinect-pty-ltd
Artg Date
2004-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c728232c3eb55ef5e20ebc7b79fa0ddb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/487f691b9367b88ed390be3567d93d92.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
b28ba4fb0a157840
Type
Standard
Back to TGA Approvals
